adenosine

Brand: Adenocard

Prototype Drug
Drug Class: antiarrhythmic (Class V)
Drug Family: antiarrhythmic
Subclass: endogenous purine nucleoside
Organ Systems: cardiovascular

Mechanism of Action

Activates A1 receptors in AV node causing transient AV block; slows or terminates AV node-dependent reentry tachycardias; very short duration of action.

A1 adenosine receptors (AV node)

Indications

  • PSVT termination (drug of choice)
  • diagnosis of wide-complex tachycardias

Contraindications

  • AF/flutter (does not convert but may cause severe bradycardia)
  • WPW with pre-excitation
  • 2nd/3rd degree AV block
  • sinus node dysfunction
  • asthma/COPD (relative — bronchospasm risk)

Adverse Effects

Common

  • flushing
  • chest tightness
  • dyspnea
  • transient AV block
  • sense of impending doom

Serious

  • transient asystole (brief)
  • bronchospasm in reactive airway disease
  • VF in WPW with rapid ventricular response

Pharmacokinetics (ADME)

Absorption IV only; rapid uptake by RBCs and endothelial cells
Distribution very low
Metabolism deamination in blood/tissues
Excretion very rapid
Half-life <10 seconds
Onset immediate
Peak immediate
Duration 10-15 seconds
Protein Binding <0%
Vd 0.33 L/kg

Drug Interactions

Drug / Agent Mechanism Severity
methylxanthines (theophylline, caffeine) competitive antagonists at A1 receptors — block adenosine effect; require higher dose major
dipyridamole blocks adenosine uptake — potentiates effect (use 1/4 dose) major

Nursing Considerations

  1. Rapid IV push (1-3 seconds) via large antecubital vein followed immediately by 20mL NS flush
  2. Warn patient about very brief side effects (flushing, chest tightness — seconds only)
  3. Theophylline and caffeine antagonize effect — may require higher doses
  4. Dipyridamole potentiates: start with 1 mg in dipyridamole-treated patients
  5. Record ECG during administration — diagnostic tool

Clinical Pearls

  • Half-life <10 seconds: adverse effects self-limited, resolving in seconds
  • Theophylline antagonism: competitive A1 blocker — may need higher dose or alternative agent
  • Not effective in non-AV-node-dependent arrhythmias (VT, AF, flutter)

Safety Profile

Pregnancy use-with-caution
Lactation insufficient-data
Renal Adjustment Not required
Hepatic Adjustment Not required
TDM Not required

Concordance Terms

Cross-referenced clinical concepts — click any term to see all content where it appears.